Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24812
Abstract: To determine the frequency of antiphospholipid antibodies (aPL) in patients with unexplained articular manifestations. read more here.
Keywords: articular manifestations; unexplained articular; anticardiolipin anti; patients unexplained ... See more keywords
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-213496
Abstract: The current management of antiphospholipid syndrome (APS) centres on attenuating the procoagulant state while balancing the haemorrhagic risks.1 This approach relies mainly on a thromboprophylaxis strategy rather than targeting pathogenic antiphospholipid antibodies (aPL)-mediated pathways. Herewith, we report… read more here.
Keywords: antiphospholipid syndrome; disappearance; systemic lupus; anticardiolipin anti ... See more keywords